JP2018516249A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516249A5 JP2018516249A5 JP2017560717A JP2017560717A JP2018516249A5 JP 2018516249 A5 JP2018516249 A5 JP 2018516249A5 JP 2017560717 A JP2017560717 A JP 2017560717A JP 2017560717 A JP2017560717 A JP 2017560717A JP 2018516249 A5 JP2018516249 A5 JP 2018516249A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- combination
- tumor tissue
- nanoparticles
- accumulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021180243A JP7263485B2 (ja) | 2015-05-29 | 2021-11-04 | フェロトーシスを介して栄養欠乏がん細胞の細胞死を誘導するための極小ナノ粒子を使用する処置方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562168636P | 2015-05-29 | 2015-05-29 | |
| US62/168,636 | 2015-05-29 | ||
| US201662280960P | 2016-01-20 | 2016-01-20 | |
| US62/280,960 | 2016-01-20 | ||
| PCT/US2016/034351 WO2016196201A1 (en) | 2015-05-29 | 2016-05-26 | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180243A Division JP7263485B2 (ja) | 2015-05-29 | 2021-11-04 | フェロトーシスを介して栄養欠乏がん細胞の細胞死を誘導するための極小ナノ粒子を使用する処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516249A JP2018516249A (ja) | 2018-06-21 |
| JP2018516249A5 true JP2018516249A5 (https=) | 2019-06-13 |
| JP6974178B2 JP6974178B2 (ja) | 2021-12-01 |
Family
ID=56134596
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560717A Active JP6974178B2 (ja) | 2015-05-29 | 2016-05-26 | フェロトーシスを介して栄養欠乏がん細胞の細胞死を誘導するための極小ナノ粒子を使用する処置方法 |
| JP2021180243A Active JP7263485B2 (ja) | 2015-05-29 | 2021-11-04 | フェロトーシスを介して栄養欠乏がん細胞の細胞死を誘導するための極小ナノ粒子を使用する処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180243A Active JP7263485B2 (ja) | 2015-05-29 | 2021-11-04 | フェロトーシスを介して栄養欠乏がん細胞の細胞死を誘導するための極小ナノ粒子を使用する処置方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10736972B2 (https=) |
| EP (1) | EP3302568B1 (https=) |
| JP (2) | JP6974178B2 (https=) |
| KR (1) | KR102730833B1 (https=) |
| CN (2) | CN108377643B (https=) |
| AU (1) | AU2016271040A1 (https=) |
| BR (1) | BR112017024328A2 (https=) |
| CA (1) | CA2985126A1 (https=) |
| HK (1) | HK1253536A1 (https=) |
| WO (1) | WO2016196201A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12161734B2 (en) | 2009-07-02 | 2024-12-10 | Sloan-Kettering Institute For Cancer Research | Multimodal silica-based nanoparticles |
| DK3223013T3 (en) | 2009-07-02 | 2019-04-15 | Sloan Kettering Inst Cancer Res | FLUORESCING SILICA-BASED NANOPARTICLES |
| CA2900363C (en) | 2013-03-15 | 2023-10-10 | Sloan-Kettering Institute For Cancer Research | Multimodal silica-based nanoparticles |
| EP3148591B1 (en) | 2014-05-29 | 2020-03-11 | Memorial Sloan Kettering Cancer Center | Nanoparticle drug conjugates |
| US10736972B2 (en) | 2015-05-29 | 2020-08-11 | Memorial Sloan Kettering Cancer Center | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis |
| WO2017189961A1 (en) | 2016-04-29 | 2017-11-02 | Memorial Sloan Kettering Cancer Center | Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors |
| EP3630089A4 (en) * | 2017-05-24 | 2021-06-09 | Ferro Therapeutics, Inc. | PROCEDURE FOR CANCER THERAPY |
| WO2018217528A1 (en) * | 2017-05-25 | 2018-11-29 | Memorial Sloan Kettering Cancer Center | Ultrasmall nanoparticles labeled with zirconium-89 and methods thereof |
| EP3645739A4 (en) * | 2017-06-28 | 2021-07-14 | The Regents of the University of California | METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA |
| US20200383943A1 (en) * | 2017-12-04 | 2020-12-10 | Memorial Sloan Kettering Cancer Center | Methods of cancer treatment via regulated ferroptosis |
| US20210074995A1 (en) | 2018-01-31 | 2021-03-11 | Lg Chem, Ltd. | Negative electrode active material, negative electrode including the same and lithium secondary battery including the same |
| JP7348906B2 (ja) | 2018-02-28 | 2023-09-21 | フェロ セラピューティクス， インコーポレイテッド | フェロトーシス誘導活性を有する化合物およびそれらの使用方法 |
| WO2019200343A1 (en) * | 2018-04-13 | 2019-10-17 | The Wistar Institute Of Anatomy And Biology | S6k2 blockade perturbs redox balance and fatty acid metabolism, leading to oxidative cell death in mapk inhibitor resistant cancers |
| US12268742B2 (en) | 2018-05-02 | 2025-04-08 | Memorial Sloan Kettering Cancer Center | Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT) |
| WO2020077361A1 (en) * | 2018-10-12 | 2020-04-16 | The General Hospital Corporation | Compounds and methods of their use |
| US12201956B2 (en) | 2018-10-16 | 2025-01-21 | Pharma In Silica Laboratories Inc. | Tunable process for silica capsules/spheres preparation and their use |
| US20220193275A1 (en) * | 2018-12-17 | 2022-06-23 | Memorial Sloan Kettering Cancer Center | Inducing favorable effects on tumor microenvironment via administration of nanoparticle compositions |
| US11040964B2 (en) | 2019-02-27 | 2021-06-22 | Ferro Therapeutics, Inc. | Compounds and methods of use |
| WO2022093800A2 (en) | 2020-10-27 | 2022-05-05 | Elucida Oncology, Inc. | Carrier particle-drug conjugates, self-immolative linkers, and uses thereof |
| CN112274495B (zh) * | 2020-10-31 | 2022-05-03 | 郑州大学 | 一种h2o2自供型过氧化钙负载姜黄素纳米粒的制备方法及其应用 |
| US20240285543A1 (en) * | 2021-06-21 | 2024-08-29 | Memorial Sloan-Kettering Cancer Center | Nanoparticle-mediated enhancement of immunotherapy to promote ferroptosis-induced cytotoxicity and antitumor immune responses |
| WO2023023288A1 (en) * | 2021-08-19 | 2023-02-23 | Arpeggio Biosciences, Inc. | Small molecule modulators of ferroptosis |
| US11541116B1 (en) | 2022-01-07 | 2023-01-03 | Kojin Therapeutics, Inc. | Methods and compositions for inducing ferroptosis in vivo |
| CN115120595B (zh) * | 2022-08-02 | 2023-06-30 | 广西医科大学第一附属医院 | Liproxstatin-1在制备防治白血病的药物中的应用和其药物组合物 |
| CN116270624A (zh) * | 2023-02-14 | 2023-06-23 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | Tubastatin A的新应用 |
| WO2025198008A1 (ja) * | 2024-03-22 | 2025-09-25 | 公益財団法人がん研究会 | フェロトーシス誘導促進剤 |
| CN118879871B (zh) * | 2024-09-27 | 2025-05-30 | 中国人民解放军总医院第三医学中心 | 一种肾癌预后标志物tymp及tymp抑制剂的应用 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3870791A (en) | 1972-04-24 | 1975-03-11 | Heskel M Haddad | Solid state ophthalmic medication delivery method |
| US3867519A (en) | 1972-04-27 | 1975-02-18 | Alza Corp | Bioerodible drug delivery device |
| US4051842A (en) | 1975-09-15 | 1977-10-04 | International Medical Corporation | Electrode and interfacing pad for electrical physiological systems |
| DE2626348C3 (de) | 1976-06-11 | 1980-01-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Implantierbare Dosiereinrichtung |
| US4136177A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Xanthan gum therapeutic compositions |
| US4255415A (en) | 1978-11-22 | 1981-03-10 | Schering Corporation | Polyvinyl alcohol ophthalmic gel |
| US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
| US4931279A (en) | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
| US4688506A (en) | 1985-09-03 | 1987-08-25 | Breems Martinus Van | Boat sail control system |
| US4788603A (en) | 1985-10-19 | 1988-11-29 | Fuji Photo Film Co., Ltd. | Camera for sequentially photographing a subject using a reference optical system and a telescopic optical system |
| US4812409A (en) | 1986-01-31 | 1989-03-14 | Eastman Kodak Company | Hydrolyzable fluorescent substrates and analytical determinations using same |
| US4713224A (en) | 1986-03-31 | 1987-12-15 | The Boc Group, Inc. | One-step process for purifying an inert gas |
| US4810636A (en) | 1986-12-09 | 1989-03-07 | Miles Inc. | Chromogenic acridinone enzyme substrates |
| US4774339A (en) | 1987-08-10 | 1988-09-27 | Molecular Probes, Inc. | Chemically reactive dipyrrometheneboron difluoride dyes |
| US5274113A (en) | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
| US5433896A (en) | 1994-05-20 | 1995-07-18 | Molecular Probes, Inc. | Dibenzopyrrometheneboron difluoride dyes |
| US5248782A (en) | 1990-12-18 | 1993-09-28 | Molecular Probes, Inc. | Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes |
| US5187288A (en) | 1991-05-22 | 1993-02-16 | Molecular Probes, Inc. | Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis |
| US5776427A (en) | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| US5830912A (en) | 1996-11-15 | 1998-11-03 | Molecular Probes, Inc. | Derivatives of 6,8-difluoro-7-hydroxycoumarin |
| CA2299471C (en) * | 1997-08-15 | 2007-12-18 | Cephalon Inc. | Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| GB2330907A (en) | 1997-10-28 | 1999-05-05 | Applied Imaging Int Ltd | A karyotyper and methods for producing karyotypes |
| ATE239801T1 (de) | 1998-01-22 | 2003-05-15 | Luminex Corp | Mikropartikel mit multiplen fluoreszenz-signalen |
| US6254852B1 (en) | 1999-07-16 | 2001-07-03 | Dupont Pharmaceuticals Company | Porous inorganic targeted ultrasound contrast agents |
| US7279150B2 (en) | 2002-01-24 | 2007-10-09 | Barnes-Jewish Hospital | Chelating agents with lipophilic carriers |
| WO2003066066A1 (en) | 2002-02-01 | 2003-08-14 | Vanderbilt University | Targeted drug delivery methods |
| US8620410B2 (en) | 2002-03-12 | 2013-12-31 | Beth Israel Deaconess Medical Center | Multi-channel medical imaging system |
| US20040101822A1 (en) | 2002-11-26 | 2004-05-27 | Ulrich Wiesner | Fluorescent silica-based nanoparticles |
| WO2004108902A2 (en) | 2003-06-04 | 2004-12-16 | Visen Medical, Inc. | Biocompatible fluorescent silicon nanoparticles |
| WO2006042233A1 (en) | 2004-10-08 | 2006-04-20 | The Cleveland Clinic Foundation | Medical imaging using quantum dots |
| US7653427B2 (en) | 2004-11-12 | 2010-01-26 | Intra-Medical Imaging LLC | Method and instrument for minimally invasive sentinel lymph node location and biopsy |
| AU2006339072A1 (en) | 2005-03-14 | 2007-10-25 | Board Of Regents Of The University Of Texas System | Bioactive FUS1 peptides and nanoparticle-polypeptide complexes |
| WO2006099445A2 (en) | 2005-03-14 | 2006-09-21 | Massachusetts Institute Of Technology | Nanocells for diagnosis and treatment of diseases and disorders |
| US8084001B2 (en) | 2005-05-02 | 2011-12-27 | Cornell Research Foundation, Inc. | Photoluminescent silica-based sensors and methods of use |
| US7601355B2 (en) | 2005-06-01 | 2009-10-13 | Northwestern University | Compositions and methods for altering immune function |
| JP2008546804A (ja) | 2005-06-24 | 2008-12-25 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | 造影剤として用いるためのリガンドの放射性標識ペグ化 |
| FR2888753B1 (fr) | 2005-07-21 | 2008-04-04 | Commissariat Energie Atomique | Vecteur cible avec fonction d'imagerie activable |
| WO2007136413A2 (en) | 2005-12-22 | 2007-11-29 | Visen Medical, Inc. | Biocompatible fluorescent metal oxide nanoparticles |
| WO2008044138A1 (en) | 2006-10-12 | 2008-04-17 | Syddansk Universitet | Optical nanosensor for detection of reactive oxygen species |
| WO2008049118A2 (en) | 2006-10-19 | 2008-04-24 | The General Hospital Corporation | Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample and effecting such portion(s) |
| US7902332B2 (en) | 2006-11-30 | 2011-03-08 | General Electric Company | Fluorine-labeled compounds |
| WO2008073856A2 (en) | 2006-12-08 | 2008-06-19 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
| US8239008B2 (en) | 2007-04-13 | 2012-08-07 | Ethicon Endo-Surgery, Inc. | Sentinel node identification using fluorescent nanoparticles |
| EP1995327A1 (en) | 2007-05-21 | 2008-11-26 | Humboldt Universität zu Berlin | Probe for detecting a particular nucleic acid sequence |
| WO2009029870A2 (en) | 2007-08-31 | 2009-03-05 | Hybrid Silica Technologies, Inc. | Peg-coated core-shell silica nanoparticles and methods of manufacture and use |
| DE102007052517A1 (de) | 2007-10-29 | 2009-04-30 | Autoimmun Diagnostika Gmbh | ELISPOT-Verfahren mit zwei Filtersystemen |
| WO2009064964A2 (en) | 2007-11-15 | 2009-05-22 | The University Of California | Switchable nano-vehicle delivery systems, and methods for making and using them |
| WO2009085218A1 (en) | 2007-12-21 | 2009-07-09 | President And Fellows Of Harvard College | Sub-diffraction limit image resolution in three dimensions |
| WO2010091294A2 (en) | 2009-02-05 | 2010-08-12 | The Regents Of The University Of California | New targeted antimicrobial moieties |
| ES2700870T3 (es) | 2009-04-15 | 2019-02-19 | Univ Cornell | Nanopartículas de sílice fluorescentes mejoradas a través de densificación de sílice |
| US9005575B2 (en) | 2009-06-12 | 2015-04-14 | Stc.Unm | Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| US12161734B2 (en) | 2009-07-02 | 2024-12-10 | Sloan-Kettering Institute For Cancer Research | Multimodal silica-based nanoparticles |
| DK3223013T3 (en) | 2009-07-02 | 2019-04-15 | Sloan Kettering Inst Cancer Res | FLUORESCING SILICA-BASED NANOPARTICLES |
| US9238069B2 (en) * | 2009-12-16 | 2016-01-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment |
| IN2012DN05099A (https=) | 2009-12-16 | 2015-10-09 | Brigham & Womens Hospital | |
| SI2528625T1 (sl) | 2010-04-15 | 2013-11-29 | Spirogen Sarl | Pirolobenzodiazepini in njihovi konjugati |
| GB201121288D0 (en) | 2011-12-12 | 2012-01-25 | Univ Muenster Wilhelms | Functionalised silicon nanoparticles |
| US9006987B2 (en) | 2012-05-07 | 2015-04-14 | Lighting Science Group, Inc. | Wall-mountable luminaire and associated systems and methods |
| US10732115B2 (en) | 2012-06-22 | 2020-08-04 | Cornell University | Mesoporous oxide nanoparticles and methods of making and using same |
| US9695133B2 (en) * | 2012-07-13 | 2017-07-04 | The Trustees Of Columbia University In The City Of New York | Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| EP2959299B1 (en) | 2013-02-20 | 2019-01-02 | Cornell University | Multilayer fluorescent nanoparticles and methods of making and using same |
| CA2900363C (en) | 2013-03-15 | 2023-10-10 | Sloan-Kettering Institute For Cancer Research | Multimodal silica-based nanoparticles |
| US10986997B2 (en) | 2013-12-31 | 2021-04-27 | Memorial Sloan Kettering Cancer Center | Systems, methods, and apparatus for multichannel imaging of fluorescent sources in real time |
| EP3148591B1 (en) | 2014-05-29 | 2020-03-11 | Memorial Sloan Kettering Cancer Center | Nanoparticle drug conjugates |
| CA2954725A1 (en) | 2014-07-25 | 2016-01-28 | Northeastern University | Biopolymer-nanoparticle composite implant for tumor cell tracking |
| EP3029032A1 (en) | 2014-12-05 | 2016-06-08 | Centre National de la Recherche Scientifique (CNRS) | Bifunctional do2pa derivatives, chelates with metallic cations and use thereof |
| RU2017122621A (ru) | 2014-12-15 | 2019-01-17 | Мемориал Слоун Кеттеринг Кэнсер Сентр | Циклические пептиды с улучшенной селективностью связывания с нервами, наночастицы, связанные с указанными циклическими пептидами, и их применение для визуализации нервной ткани in vivo в реальном времени |
| JP6869187B2 (ja) | 2015-04-07 | 2021-05-12 | メモリアル スローン ケタリング キャンサー センター | ナノ粒子イムノコンジュゲート |
| US11291737B2 (en) | 2015-05-04 | 2022-04-05 | Cornell University | Ultrasmall nanoparticles and methods of making and using same |
| US10736972B2 (en) | 2015-05-29 | 2020-08-11 | Memorial Sloan Kettering Cancer Center | Methods of treatment using ultrasmall nanoparticles to induce cell death of nutrient-deprived cancer cells via ferroptosis |
| US20180296595A1 (en) | 2015-09-11 | 2018-10-18 | Memorial Sloan Kettering Cancer Center | Methods and compositions for cancer treatment |
| US11660354B2 (en) | 2016-11-30 | 2023-05-30 | Memorial Sloan Kettering Cancer Center | Inhibitor-functionalized ultrasmall nanoparticles and methods thereof |
| WO2018191316A1 (en) | 2017-04-10 | 2018-10-18 | Cornell University | Sulfur- or heavy atom-containing nanoparticles, methods of making same, and uses thereof |
| JP7309198B2 (ja) | 2017-05-19 | 2023-07-18 | コーネル ユニバーシティー | 機能性ナノ粒子及びそれを製造する方法並びに使用する方法 |
| EP3630089A4 (en) | 2017-05-24 | 2021-06-09 | Ferro Therapeutics, Inc. | PROCEDURE FOR CANCER THERAPY |
| WO2018217528A1 (en) | 2017-05-25 | 2018-11-29 | Memorial Sloan Kettering Cancer Center | Ultrasmall nanoparticles labeled with zirconium-89 and methods thereof |
| EP3642599B1 (en) | 2017-06-23 | 2025-01-08 | Memorial Sloan-Kettering Cancer Center | Method of imaging in vivo tissues using nanoparticles comprising a reference dye and a sensor dye. |
| US20200383943A1 (en) | 2017-12-04 | 2020-12-10 | Memorial Sloan Kettering Cancer Center | Methods of cancer treatment via regulated ferroptosis |
-
2016
- 2016-05-26 US US15/573,855 patent/US10736972B2/en active Active
- 2016-05-26 HK HK18112736.4A patent/HK1253536A1/zh unknown
- 2016-05-26 BR BR112017024328A patent/BR112017024328A2/pt not_active Application Discontinuation
- 2016-05-26 AU AU2016271040A patent/AU2016271040A1/en not_active Abandoned
- 2016-05-26 CA CA2985126A patent/CA2985126A1/en not_active Abandoned
- 2016-05-26 EP EP16730103.5A patent/EP3302568B1/en active Active
- 2016-05-26 JP JP2017560717A patent/JP6974178B2/ja active Active
- 2016-05-26 KR KR1020177037129A patent/KR102730833B1/ko active Active
- 2016-05-26 CN CN201680035303.4A patent/CN108377643B/zh active Active
- 2016-05-26 CN CN202111011162.1A patent/CN113559279A/zh active Pending
- 2016-05-26 WO PCT/US2016/034351 patent/WO2016196201A1/en not_active Ceased
-
2020
- 2020-06-16 US US16/902,577 patent/US11246946B2/en active Active
-
2021
- 2021-11-04 JP JP2021180243A patent/JP7263485B2/ja active Active
- 2021-12-30 US US17/566,015 patent/US11931425B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516249A5 (https=) | ||
| Sukumar et al. | Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide | |
| Kang et al. | Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier | |
| Islam et al. | Augmentation of the enhanced permeability and retention effect with nitric oxide–generating agents improves the therapeutic effects of nanomedicines | |
| Xiao et al. | Engineering nanoparticles for targeted delivery of nucleic acid therapeutics in tumor | |
| Jang et al. | The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo | |
| Wu et al. | PDA-based drug delivery nanosystems: a potential approach for glioma treatment | |
| Kotagiri et al. | Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer | |
| Li et al. | LHRH-targeted drug delivery systems for cancer therapy | |
| Gu et al. | Nanodiamond-mediated delivery of a G9a inhibitor for hepatocellular carcinoma therapy | |
| Saini et al. | Transferrin-conjugated polymer-coated mesoporous silica nanoparticles loaded with gemcitabine for killing pancreatic cancer cells | |
| Kumar et al. | Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study | |
| Huang et al. | Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment | |
| Cruje et al. | Polyethylene glycol functionalized nanoparticles for improved cancer treatment | |
| Karpisheh et al. | RETRACTED: Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells | |
| Li et al. | Ultrasound-enhanced delivery of doxorubicin-loaded nanodiamonds from pullulan-all-trans-retinal nanoparticles for effective cancer therapy | |
| Lee et al. | The effect of ligand density on in vivo tumor targeting of nanographene oxide | |
| Zhao et al. | Inhalable siRNA nanoparticles for enhanced tumor-targeting treatment of KRAS-mutant non-small-cell lung cancer | |
| Lee et al. | Integration of PEG and PEI with graphene quantum dots to fabricate pH-responsive nanostars for colon cancer suppression in vitro and in vivo | |
| Shi et al. | Multiscale bioresponses of metal nanoclusters | |
| WO2016153920A1 (en) | Mesoscale nanoparticles for selective targeting to the kidney and methods of their therapeutic use | |
| Zhang et al. | Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer | |
| Chowdhury et al. | Paclitaxel-loaded biotinylated fe2+-doped carbon dot: combination therapy in cancer treatment | |
| Ding et al. | Versatile reticular polyethylenimine derivative-mediated targeted drug and gene codelivery for tumor therapy | |
| Razzaq et al. | Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems |